Verastem Oncology
VSTM
#8084
Rank
NZ$0.31 B
Marketcap
$7.00
Share price
-6.82%
Change (1 day)
-35.50%
Change (1 year)

Earnings for Verastem Oncology (VSTM)

Earnings in 2024 (TTM): -NZ$0.15 Billion

According to Verastem Oncology 's latest financial reports the company's current earnings are NZ$10 Million. In 2023 the company made an earning of -NZ$0.15 Billion a decrease over its 2022 earnings that were of -NZ$0.13 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Verastem Oncology from 2011 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$0.15 Billion-1.42%
2023 -NZ$0.15 Billion18.36%
2022 -NZ$0.13 Billion3.67%
2021 -NZ$0.13 Billion5.43%
2020 -NZ$0.12 Billion-54.74%
2019 -NZ$0.26 Billion105.99%
2018 -NZ$0.13 Billion6.83%
2017 -NZ$0.12 Billion86.06%
2016 -NZ$62.18 Million-37.03%
2015 -NZ$98.73 Million8.43%
2014 -NZ$91.06 Million29.52%
2013 -NZ$70.3 Million28.6%
2012 -NZ$54.67 Million133.9%
2011 -NZ$23.38 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$79.53 Million-47.92%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$2.07 Billion 1,254.33%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1.40 B-1,018.86%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$7.11 B-4,760.66%๐Ÿ‡ฌ๐Ÿ‡ง UK